Skip to main content
. Author manuscript; available in PMC: 2013 Jul 24.
Published in final edited form as: Expert Rev Neurother. 2011 Aug;11(8):1175–1183. doi: 10.1586/ern.11.86

Table 1.

Controlled studies on steroid therapy of neurocysticercosis.

Study (year) Details Entry criteria Intervention Imaging results (resolution) Seizures Ref.
Mall et al. (2003) Randomized, not blinded. All ages Seizure <10 days and SEL 1 mg/kg prednisolone × 10 days with 4-day taper Significantly improved in steroid group (88 vs 52%) at 6 months Significantly fewer in steroid group (2 vs 13%) at 6 months [45]
Garg et al. (2006) Randomized, blinded. All ages. Seizure <14 days and SEL 1 mg/kg prednisolone × 10 days with 4-day taper No difference at 6 months Significantly fewer in steroid group (12 vs 48%) at 9 months [46]
Prakash et al. (2006) Randomized. All ages Seizure <14 days and SEL 1 g/1.72 m2 iv. methyl prednisolone × 5 days Significantly improved in steroid group (60 vs 18.5%) at 2 months No significant decrease in seizures in steroid group (16 vs 33%) [48]
Kishore et al. (2007) Randomized. All ages Seizure <7 days and SEL 1 mg/kg prednisolone × 7 days + 3-day taper Significantly improved in steroid group (68 vs 53%) at 8–12 weeks Significantly fewer seizures in steroid group (10.6 vs 26.7%) [47]

iv.: Intravenous; SEL: Single enhancing granulomatous lesion.